Boothbay Fund Management, LLC Xencor Inc Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $185,861 - $216,363	-6,064 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $208,177 - $270,939	6,064 New	6,064 $209,000
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $221,369 - $303,670	-6,563 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $194,264 - $268,623	6,563 New	6,563 $269,000

204

63.1M

3.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.27B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.